ES8604571A1 - Un derivado de indol-3-carboxamida - Google Patents

Un derivado de indol-3-carboxamida

Info

Publication number
ES8604571A1
ES8604571A1 ES538418A ES538418A ES8604571A1 ES 8604571 A1 ES8604571 A1 ES 8604571A1 ES 538418 A ES538418 A ES 538418A ES 538418 A ES538418 A ES 538418A ES 8604571 A1 ES8604571 A1 ES 8604571A1
Authority
ES
Spain
Prior art keywords
group
formula
alkyl group
compound
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES538418A
Other languages
English (en)
Spanish (es)
Other versions
ES538418A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical Industries Ltd filed Critical Yoshitomi Pharmaceutical Industries Ltd
Publication of ES8604571A1 publication Critical patent/ES8604571A1/es
Publication of ES538418A0 publication Critical patent/ES538418A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S47/00—Plant husbandry
    • Y10S47/01—Methods of plant-breeding and including chromosome multiplication

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
ES538418A 1983-12-08 1984-12-07 Un derivado de indol-3-carboxamida Expired ES8604571A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58232514A JPS60123485A (ja) 1983-12-08 1983-12-08 インド−ル−３−カルボキサミド誘導体

Publications (2)

Publication Number Publication Date
ES8604571A1 true ES8604571A1 (es) 1986-02-01
ES538418A0 ES538418A0 (es) 1986-02-01

Family

ID=16940520

Family Applications (1)

Application Number Title Priority Date Filing Date
ES538418A Expired ES8604571A1 (es) 1983-12-08 1984-12-07 Un derivado de indol-3-carboxamida

Country Status (8)

Country Link
US (1) US4616009A (enExample)
EP (1) EP0144986B1 (enExample)
JP (1) JPS60123485A (enExample)
KR (1) KR910006863B1 (enExample)
AT (1) ATE25682T1 (enExample)
CA (1) CA1279319C (enExample)
DE (1) DE3462504D1 (enExample)
ES (1) ES8604571A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814277D0 (en) * 1988-06-16 1988-07-20 Glaxo Group Ltd Chemical compounds
US5166341A (en) * 1988-07-29 1992-11-24 Dainippon Pharmaceutical Co., Ltd. 6-amino-1,4-hexahydro-1H-diazepine derivatives
US5017573A (en) * 1988-07-29 1991-05-21 Dainippon Pharmaceutical Co., Ltd. Indazole-3-carboxylic acid derivatives
JPH0255357U (enExample) * 1988-10-07 1990-04-20
CA2030051C (en) * 1989-11-17 2001-08-07 Haruhiko Kikuchi Indole derivatives
JPH03206584A (ja) * 1990-01-09 1991-09-09 Nec Home Electron Ltd Ｉｃカードのロック機構
US5189054A (en) * 1990-11-02 1993-02-23 Merrell Dow Pharmaceuticals Inc. 3-amidoindolyl derivatives and pharmaceutical compositions thereof
AU641052B2 (en) * 1990-11-02 1993-09-09 Aventisub Ii Inc. 3-amidoindolyl derivatives
GB9103862D0 (en) * 1991-02-25 1991-04-10 Glaxo Group Ltd Chemical compounds
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
JP3037108U (ja) * 1996-10-22 1997-05-06 カシオ計算機株式会社 電子機器におけるロック機構
EP1433782A4 (en) * 2001-09-10 2005-04-27 Mercian Corp PROCESS FOR PREPARING A PIPECOLAMID DERIVATIVE
EP1644362A2 (en) * 2003-07-02 2006-04-12 Sugen, Inc. Indolinone hydrazides as c-met inhibitors
US7977359B2 (en) * 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) * 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US20070244128A1 (en) * 2005-11-04 2007-10-18 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein (flap) inhibitors
US20070219206A1 (en) * 2005-11-04 2007-09-20 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein (flap) inhibitors
US20070225285A1 (en) * 2005-11-04 2007-09-27 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein (flap) inhibitors
UA95084C2 (en) * 2005-11-04 2011-07-11 Амира Фармасутикалз, Инк. 5-lipoxygenase-activating protein (flap) inhibitors
US8399666B2 (en) * 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
TW200920369A (en) * 2007-10-26 2009-05-16 Amira Pharmaceuticals Inc 5-lipoxygenase activating protein (flap) inhibitor
JP5791500B2 (ja) * 2008-05-23 2015-10-07 パンミラ ファーマシューティカルズ，エルエルシー． ５−リポキシゲナーゼ活性化タンパク質阻害剤
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
RS59473B1 (sr) 2015-09-10 2019-12-31 Suven Life Sciences Ltd Fluoroindol derivati kao pozitivni alosterički modulatori muskarinskog m1 receptora

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1173148A (fr) * 1956-03-19 1959-02-20 Rhone Poulenc Sa Nouveaux dérivés de l'indole et leur préparation
US3136770A (en) * 1960-04-01 1964-06-09 Neisler Lab Inc Indolyl substituted piperidines
US3238215A (en) * 1963-10-17 1966-03-01 Sterling Drug Inc 1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines
GB1273563A (en) * 1968-07-24 1972-05-10 Wyeth John & Brother Ltd Indoles
GB1345872A (en) * 1970-09-03 1974-02-06 Wyeth John & Brother Ltd Amino-and acylamino-pyridine and hydropyridine derivatives
GB1543619A (en) * 1976-03-12 1979-04-04 Wyeth John & Brother Ltd Process for preparing 3-(heterocycloalkyl)-indole derivatives

Also Published As

Publication number Publication date
EP0144986A2 (en) 1985-06-19
EP0144986A3 (en) 1985-07-24
KR910006863B1 (ko) 1991-09-09
EP0144986B1 (en) 1987-03-04
US4616009A (en) 1986-10-07
JPS6348272B2 (enExample) 1988-09-28
KR850004482A (ko) 1985-07-15
DE3462504D1 (de) 1987-04-09
ATE25682T1 (de) 1987-03-15
CA1279319C (en) 1991-01-22
JPS60123485A (ja) 1985-07-02
ES538418A0 (es) 1986-02-01

Similar Documents

Publication Publication Date Title
ES8604571A1 (es) Un derivado de indol-3-carboxamida
ES8506696A1 (es) Un procedimiento para la preparacion de 1-(4-(4,4-dialquil-2,6-piperidindion-1-il)butil)piperazinas.
ES8407049A1 (es) Un procedimiento para la preparacion de compuestos biciclicos.
PL289935A1 (en) Method of obtaining novel derivatives of 4h-pyrido-(1,2-a) pyrimidone-4
DK513080A (da) 6-(1-hydroxyethyl)-2-(2-aminoethylthio)-1,1-disubstituerede 1-carbadethiapen-2-em-3-carboxylsyrer og fremgangsmaade til fremstilling deraf
PT73050A (fr) Procede de preparation de nouveaux derives de l'acide 4-hydroxy-3-quinoleine carboxylique substitues en 2
ATE18549T1 (de) 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
ES2006994A6 (es) Procedimiento para la preparacion de derivados de los acidos quinolincarboxilicos.
ES8601209A1 (es) Procedimiento para preparar derivados de 5h-(1)-benzopirano-(2,3-d)pirimidina
SE8305917D0 (sv) Mellanprodukter for anvendning vid framstellning av hexahydro-gamma-karbolinforeningar
NO167029C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinkarboksylsyrederivater
FI74000B (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara nya alkylaminoalkyloxi-bensoyl-indolizinderivat.
NO873097L (no) Fremstilling av 1-methylaminokinolincarboxylsyrederivater.
DK133083A (da) Fremgangsmaade til fremstilling af phenylalkyloxirancarboxylsyrer
MX5687E (es) Procedimiento para la preparacion de derivados imidazo(1,2-alpha)-imidazol substituidos
SE8603792L (sv) Nya bicykliska katekolderivat, forfarande for framstellning derav och terapeutiska kompositioner innehallande dem
ZA807905B (en) 2-phenylamino-imidazolines-(2),compositions thereof and process for the preparation thereof
KR850004758A (ko) 피라졸로 피리딘 유도체의 제법
FI803887L (fi) Nya substituerade 2-fenylamino-imidazoliner-(2) deras syraadditionssalter dessa innehaollande laekemedel och deras framstaellningsfoerfarande
ES8603818A1 (es) Un metodo para preparar un derivado de acido benzoilpropio- nico
ES514639A0 (es) Procedimiento para la obtencion de amidinas de acido carboxilico n,n'-punteadas.
HUT40067A (en) Process for producing benzoic acid derivatives and pharmaceutical compositions containing them as active agents
TH2974A (th) อนุพันธ์ควิโนโลนคาร์บอกซิลิคแอซิด
JPS5285140A (en) Novel 2-(substituted phenyl)alkanoic acids or non-toxic salts thereof, or anti-inflammatory, analgesic, or antirheumatic drugs containing sa me
TH4042B (th) อนุพันธ์ควิโนโลนคาร์บอกซิลิคแอซิด

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19960603